Six patients (11.5%) had a coagulation disorder: 4 had an isolated hyperhomocysteinemia, 1 had circulating anticoagulant antibody and hyperhomocysteinemia, and 1 had a Prothrombin G20210A mutation. This evidence concerns the gene F2 and blood coagulation disease.